Evidence map›Paper›PMID 30458780›Full record

ArticleBMC health services research2018

Assessment of the development of assisted reproductive technology in Liaoning province of China, from 2012 to 2016.

Yuan-Yuan Fang, Qi-Jun Wu, Tie-Ning Zhang, Tian-Ren Wang, Zi-Qi Shen, Jiao Jiao, Xiao-Guang Shao, Peng Xu, Shuai-Shuai Guo, Yi-Ming Zhou and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Precise Personalized Medicine in Gynecology Cancer and Infertility.Frontiers in cell and developmental biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yuan-Yuan FangCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Qi-Jun WuDepartment of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Tie-Ning ZhangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Tian-Ren WangDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, 06520, USA.
Zi-Qi ShenCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Jiao JiaoCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Xiao-Guang ShaoReproductive and Genetic Medicine Center, Dalian Municipal Women's and Children's Medical Center, Dalian, 116031, China.
Peng XuCenter of Human Reproduction and Genetics, Jinghua Hospital, Shenyang, 110000, China.
Shuai-Shuai GuoCenter of Reproductive Medicine, Shenyang Women's and Children's Hospital, Shenyang, 110011, China.
Yi-Ming ZhouDepartment of Medicine, Brigham and Women's Hospital, Harvard Institutes of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Xiu-Xia WangCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China. wangxx@sj-hospital.org.
Da LiCenter of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China. leeda@ymail.com.ORCID http://orcid.org/0000-0002-4895-1185
China Medical University · CNBrigham and Women's Hospital · USShenyang First People's Hospital · CNYale University · US

Funding

Campus Research Fund of China Medical University YQ20160004Distinguished Talent Program of Shengjing Hospital ME76Fok Ying Tung Education Foundation 151039Liaoning Province Science and Technology Project 201602864National Natural Science Foundation of China 81402130National Natural Science Foundation of China 81602918National Natural Science Foundation of China 81671423Shenyang Science and Technology Bureau (CN) 17-231-1-55
6 · The paper itself

Abstract

backgroundThe development of assisted reproduction techniques (ART) has resulted in rapid advances in the treatment of infertility. However, a systematic assessment of ART and its processes and outcomes in China has never been carried out. The goal of this study was to assess the features of ART status from 2012 to 2016 in clinics and in vitro fertilization (IVF) laboratories in Liaoning, the largest IVF province in the northeast of China.

methodsData from Jan 1, 2012 to Dec 31, 2016 was retrieved from the assisted reproductive certificate registry of Liaoning province. We extracted data from: i) fresh and thawed cycles; ii) donor sperm and donor egg cycles; iii) intrauterine insemination with husband semen and donor semen (AIH and AID).

resultsWe showed that: (i) there has been a significant increase in the number of IVF fresh and thawed cycles, and the proportion of cases of primary infertility and secondary infertility has decreased and increased, respectively; (ii) standard long GnRH agonist was the major ovarian stimulation protocol. During the observation period, increasing trends in the use of GnRH antagonists, mild stimulation, and natural cycles were observed; (iii) significant differences in the number of cycles, number of retrieved oocytes, fertilization rates, implantation rates, and sex ratio were noticed between conventional IVF and intracytoplasmic sperm injection; (iv) significant differences in age at treatment for infertility, number of cycles, and ectopic pregnancy rates were noticed between donor sperm cycles and donor egg cycles; (v) significant differences in number of thawed cycles, number of thawed embryos, embryo recovery rates, implantation rates, and clinical pregnancy rates were noticed between day 3 and day 5 embryos; (vi) significant differences in age at treatment for infertility, number of cycles, clinical pregnancy rates, ectopic pregnancy rates, and live birth ratio were noticed between AIH and AID.

conclusionsART in Liaoning province has undergone substantial development from 2012 to 2016 in clinics and IVF laboratories. This presentation of detailed ART data will provide researchers, policy makers, and potential ART users a rich source of information about IVF characteristics in the northeast of China.

Indexed as

Pregnancy OutcomeChinaFemaleFertilization in VitroHumansInfertility, FemaleInfertility, MaleMaleOvulation InductionPregnancyPregnancy RateRegistriesReproductive Techniques, AssistedRetrospective StudiesSperm Injections, IntracytoplasmicAssisted reproduction techniquesChinaIn vitro fertilizationLiaoning provinceTime trend

Identifiers

PMID30458780
PMCPMC6247526
OpenAlexW2900518084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.